What dose of propylthiouracil (PTU) is equivalent to 15 mg of Thyrozol (carbimazole)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Thyrozol 15 mg Equivalent Dose

Thyrozol (carbimazole) 15 mg is approximately equivalent to 150 mg of propylthiouracil (PTU) daily.

Dose Conversion Rationale

The conversion is based on established pharmacological equivalencies between these antithyroid medications:

Carbimazole to Methimazole Conversion

First, carbimazole must be converted to its active metabolite. 10 mg of carbimazole converts to approximately 6 mg of methimazole (MMI) 1. Therefore:

  • 15 mg carbimazole = approximately 9 mg methimazole

Methimazole to PTU Conversion

The standard conversion ratio used in clinical practice is approximately 1:10 to 1:20 (MMI:PTU), with most sources supporting a 1:10 to 1:15 ratio for therapeutic equivalence 2, 3.

Using the conservative 1:15-20 ratio:

  • 9 mg methimazole ≈ 135-180 mg PTU
  • Practical equivalent: 150 mg PTU daily

Important Clinical Considerations

Why This Conversion Matters Less Than You Think

Methimazole (and thus carbimazole) should be the preferred agent in virtually all cases 1. The American Thyroid Association guidelines explicitly recommend methimazole over PTU except in three specific situations 1:

  1. First trimester of pregnancy - PTU preferred due to lower risk of congenital anomalies 4, 5
  2. Thyroid storm - Though recent evidence questions this preference 6
  3. Minor reactions to methimazole in patients refusing radioactive iodine or surgery

Critical Safety Differences

PTU carries significantly higher hepatotoxicity risk 1, 5:

  • PTU causes 2.40 times higher odds of liver injury (OR 2.40,95% CI 1.16-4.96) 5
  • PTU causes 3.96 times higher odds of elevated transaminases (OR 3.96,95% CI 2.49-6.28) 5
  • PTU can cause fulminant hepatic necrosis requiring liver transplantation 1
  • FDA issued safety alerts regarding PTU-associated severe liver injury 1

Dosing Practicality Issues

PTU requires multiple daily doses (2-3 times daily) due to shorter half-life (1-2 hours), while carbimazole/methimazole can be given once daily (half-life 3-5 hours) 1, 3. This makes:

  • PTU 150 mg = 50 mg three times daily 7
  • Carbimazole 15 mg = once daily dosing

Clinical Recommendation

If you are considering switching from Thyrozol 15 mg to PTU, reconsider whether this switch is truly necessary. The only compelling indication for PTU over carbimazole/methimazole is first-trimester pregnancy 1, 4. Otherwise, the increased hepatotoxicity risk, inconvenient dosing schedule, and lack of superior efficacy make PTU a suboptimal choice 2, 5.

If the switch is unavoidable, start with PTU 150 mg daily (50 mg three times daily) and monitor thyroid function tests at 4 weeks, adjusting based on response 1, 7.

References

Guideline

hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the american thyroid association and american association of clinical endocrinologists.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2011

Research

Clinical pharmacokinetics of antithyroid drugs.

Clinical pharmacokinetics, 1981

Research

SIDE EFFECTS OF PTU AND MMI IN THE TREATMENT OF HYPERTHYROIDISM: A SYSTEMATIC REVIEW AND META-ANALYSIS.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.